Real-World CAR-T Data Update - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

RESCHEDULED: Real-World CAR-T Data Update

RESCHEDULED: Real-World CAR-T Data Update image

RESCHEDULED: Real-World CAR-T Data Update

Webinar
event Mar 18, 2024 / 01:00PM - 02:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Myeloma patients and their loved ones have been learning about the novel CAR-T therapies that are significantly improving myeloma care. A lot of the information we have comes from clinical trials. What are we learning in the clinic about CAR-T, including how older patients are responding, what long-term side effects look like, and more?

Come with your questions and get ready to learn with us!

Schedule & Agenda

The panelist Audrey Burton-Bethke
1:00 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Sham Mailankody, MBBS.

The panelist Sham Mailankody, MBBS
1:05 PM
Presentation
Sham Mailankody, MBBS

Dr. Sham Mailankody discusses how real-world data is informing us about novel CAR-T therapies.

 

Event panelist Audience
1:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Sham Mailankody, MBBS
Sham Mailankody, MBBS

I am a medical oncologist specializing in the care of people with multiple myeloma and related plasma cell disorders. With my colleagues at Memorial Sloan Kettering Cancer Center (MSK), I am focused on identifying optimal treatment strategies for people with these disorders. My research focuses on the development of novel immune and cellular therapies, including chimeric antigen receptor (CAR) T cell therapies, for patients with myeloma. I also serve as the Clinical Director of the Cellular Therapy Service and the Research Director of the Myeloma Service at MSK.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Treatment & Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.